Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
2012 |
| gptkbp:ATCCode |
gptkb:A06AX04
|
| gptkbp:brand |
gptkb:linaclotide
|
| gptkbp:chemicalFormula |
C59H79N15O21S6
|
| gptkbp:contraindication |
pediatric patients under 6 years
known or suspected mechanical gastrointestinal obstruction |
| https://www.w3.org/2000/01/rdf-schema#label |
Linzess
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Allergan
gptkb:Ironwood_Pharmaceuticals |
| gptkbp:mechanismOfAction |
guanylate cyclase-C agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
abdominal pain bloating flatulence |
| gptkbp:usedFor |
chronic idiopathic constipation
irritable bowel syndrome with constipation |
| gptkbp:bfsParent |
gptkb:linaclotide
|
| gptkbp:bfsLayer |
6
|